$3.48T
Total marketcap
$117.56B
Total volume
BTC 61.11%     ETH 8.69%
Dominance

Recursion Pharmaceuticals RXRX Stock

4.55 USD {{ price }} 0.886917% {{change_pct}}%
Exchange
NasdaqGS
Market Cap
1.85B USD
LOW - HIGH [24H]
4.4 - 4.65 USD
VOLUME [24H]
14.54M USD
{{ volume }}
P/E Ratio
0
Earnings per share
-1.8 USD

Recursion Pharmaceuticals Price Chart

Recursion Pharmaceuticals RXRX Financial and Trading Overview

Recursion Pharmaceuticals stock price 4.55 USD
Previous Close 4.39 USD
Open 4.52 USD
Bid 4.29 USD x 5100
Ask 4.33 USD x 100
Day's Range 4.31 - 4.63 USD
52 Week Range 3.79 - 12.36 USD
Volume 14.83M USD
Avg. Volume 24.53M USD
Market Cap 1.76B USD
Beta (5Y Monthly) 0.984
PE Ratio (TTM) N/A
EPS (TTM) -1.8 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 7.43 USD

RXRX Valuation Measures

Enterprise Value 1.35B USD
Trailing P/E N/A
Forward P/E -2.50289
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 29.438425
Price/Book (mrq) 1.8842471
Enterprise Value/Revenue 22.653
Enterprise Value/EBITDA -2.577

Trading Information

Recursion Pharmaceuticals Stock Price History

Beta (5Y Monthly) 0.984
52-Week Change -54.32%
S&P500 52-Week Change 8.39%
52 Week High 12.36 USD
52 Week Low 3.79 USD
50-Day Moving Average 5.66 USD
200-Day Moving Average 6.72 USD

RXRX Share Statistics

Avg. Volume (3 month) 24.53M USD
Avg. Daily Volume (10-Days) 20.32M USD
Shares Outstanding 399.66M
Float 388.7M
Short Ratio 4.12
% Held by Insiders 3.14%
% Held by Institutions 77.69%
Shares Short 93.12M
Short % of Float 24.70%
Short % of Shares Outstanding 22.91%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2024
Most Recent Quarter (mrq) March 31, 2025
Next Fiscal Year End December 31, 2025

Profitability

Profit Margin 0%
Operating Margin (ttm) -1297.84%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -38.51%
Return on Equity (ttm) -86.10%

Income Statement

Revenue (ttm) 59.79M USD
Revenue Per Share (ttm) 0.19 USD
Quarterly Revenue Growth (yoy) 6.90%
Gross Profit (ttm) -372606016 USD
EBITDA -525584000 USD
Net Income Avi to Common (ttm) -574774976 USD
Diluted EPS (ttm) -1.8
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 500.45M USD
Total Cash Per Share (mrq) 1.23 USD
Total Debt (mrq) 92.91M USD
Total Debt/Equity (mrq) 9.95 USD
Current Ratio (mrq) 4.114
Book Value Per Share (mrq) 2.298

Cash Flow Statement

Operating Cash Flow (ttm) -388831008 USD
Levered Free Cash Flow (ttm) -204879504 USD

Profile of Recursion Pharmaceuticals

Country United States
State UT
City Salt Lake City
Address 41 South Rio Grande Street
ZIP 84101
Phone 385 269 0203
Website https://www.recursion.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 800

Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology and chemistry by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery in the United States. The company develops REC-994, which is in Phase 2 clinical trial to treat cerebral cavernous malformation; REC-2282, which is in Phase 2/3 clinical trial for the treatment of neurofibromatosis type 2; REC-4881, which is in Phase 1b/2 clinical trial to treat familial adenomatous polyposis; REC-3964, which is in Phase 1 clinical trial to treat Clostridioides difficile infection; and REC-4881, which is in Phase 2 clinical trial to treat AXIN1 or APC mutant cancers. Its preclinical stage product includes RBM39 to treat HR-proficient ovarian cancer. The company has collaboration and agreement with Bayer AG; the University of Utah Research Foundation; Ohio State Innovation Foundation; Roche & Genentech; and Takeda Pharmaceutical Company Limited. Recursion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Salt Lake City, Utah.

Q&A For Recursion Pharmaceuticals Stock

What is a current RXRX stock price?

Recursion Pharmaceuticals RXRX stock price today per share is 4.55 USD.

How to purchase Recursion Pharmaceuticals stock?

You can buy RXRX shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Recursion Pharmaceuticals?

The stock symbol or ticker of Recursion Pharmaceuticals is RXRX.

Which industry does the Recursion Pharmaceuticals company belong to?

The Recursion Pharmaceuticals industry is Biotechnology.

How many shares does Recursion Pharmaceuticals have in circulation?

The max supply of Recursion Pharmaceuticals shares is 406.5M.

What is Recursion Pharmaceuticals Price to Earnings Ratio (PE Ratio)?

Recursion Pharmaceuticals PE Ratio is now.

What was Recursion Pharmaceuticals earnings per share over the trailing 12 months (TTM)?

Recursion Pharmaceuticals EPS is -1.8 USD over the trailing 12 months.

Which sector does the Recursion Pharmaceuticals company belong to?

The Recursion Pharmaceuticals sector is Healthcare.

Recursion Pharmaceuticals RXRX included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
NASDAQ Composite IXIC 19142.72 USD
-0.38
8.1B USD 19015.63 USD 19186.69 USD 8.1B USD
NASDAQ Global Select Market Com NQGS 9365.63 USD
-0.4
9303.41 USD 9387.8 USD
Stlmt ID NASDAQ Biotechnology NBX 3995.9 USD
-4.37
4555.41 USD 4917.8 USD
Nasdaq US 700 Small Cap Index NQUS700SC 2227.13 USD
+0.03
2216.57 USD 2233.85 USD
Nasdaq AlphaDEX Multi Cap Growt NQDXUSMLTCG 2999.52 USD
-0.31
2987.77 USD 3004.39 USD
NASDAQ Biotechnology NBI 4177.94 USD
+1.55
4103.9 USD 4188.28 USD
Nasdaq Health Care IXHC 955.99 USD
+0.93
944.04 USD 957.7 USD